Evaluation of the antifungal efficacy of Acanthus ilicifolius L. extract ointment in canine mycotic dermatitis
Annals of Phytomedicine An International Journal · 2026-06 · 15 (1)
DOI: 10.54085/ap.2026.15.1.64 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Phytomedicine An International Journal, 2026-06. Verfasst von A. S. Khairmode und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Canine mycotic dermatitis remains a longstanding challenge in veterinary practice and might resulted due to growing resistance of current antifungals and adverse effects associated with them.A mangrove-associated medicinal plant, Acanthus ilicifolius L. (Family: Acanthaceae), and documented anti-inflammatory and antifungal properties with its bioactive phytoconstituents including flavonoids, triterpenoids, alkaloids, and phenolic acids.The study was designed to evaluate the antifungal potential and systemic safety of a prepared topical ointment using methanolic extract of A. ilicifolius leaves in naturally occurring canine mycotic dermatitis.Confirmed diagnosed 30 cases were recruited in the study and divided in ten animals in each.Group I received 2% topical ketoconazole; Group II received 5% w/w formulation; and Group III received 10% w/w formulation of extract in ointment form.Clinical, mycological, haematological, and biochemical parameters were assessed at Day 0 and Day 28 of the study.Extraction yield was found to be 18.8%.Both formulations exhibited acceptable physicochemical properties (pH 6.2-6.4).Principal fungal isolates from all the subjects were Aspergillus spp.(26.67%),Microsporum canis (23.33%),Candida albicans (20.00%),Malassezia pachydermatis (16.67%), and Trichophyton mentagrophytes (13.33%).In vitro antifungal activity on agar well was concentration-dependent. Clinically, a complete cure was achieved in 66.7% of cases and marked improvement in the remaining 33.3%, with no treatment failures.Group III (10% extract) attained a 60% recovery rate, approaching Group I (70%), and significantly surpassing Group II (50%).Significant reductions in total leucocyte counts and eosinophil percentages confirmed resolution of systemic fungal inflammation.Serum alkaline phosphatase declined significantly across all treated groups, with F1 showing the greatest absolute reduction, suggesting hepatoprotective activity.No adverse reactions or pathological haemato-biochemical changes were recorded, confirming a safety profile as per ketoconazole.These findings establish A. ilicifolius extract ointment as a promising, cost-effective phytotherapeutic alternative for canine mycotic dermatitis.
Zitieren
APA
Khairmode, A. S., Karande, V. V., Ghumare, B. C., Tumlam, U. M., Ambore, B. N., Jadhav, S. N., & Bukke, M. B. (2026). Evaluation of the antifungal efficacy of Acanthus ilicifolius L. extract ointment in canine mycotic dermatitis. Annals of Phytomedicine An International Journal, 15(1). https://doi.org/10.54085/ap.2026.15.1.64
Vancouver
Khairmode AS, Karande VV, Ghumare BC, Tumlam UM, Ambore BN, Jadhav SN, et al. Evaluation of the antifungal efficacy of Acanthus ilicifolius L. extract ointment in canine mycotic dermatitis. Annals of Phytomedicine An International Journal. 2026;15(1). doi:10.54085/ap.2026.15.1.64
BibTeX
@article{Khairmode2026,
author = {Khairmode, A. S. and Karande, V. V. and Ghumare, B. C. and Tumlam, U. M. and Ambore, B. N. and Jadhav, S. N. and Bukke, M. B.},
title = {Evaluation of the antifungal efficacy of Acanthus ilicifolius L. extract ointment in canine mycotic dermatitis},
journal = {Annals of Phytomedicine An International Journal},
year = {2026},
volume = {15},
number = {1},
doi = {10.54085/ap.2026.15.1.64}
}
EUVIMED